Journal of Clinical Endocrinology & Metabolism, Vol 80, 160-164, Copyright © 1995 by Endocrine Society

ARTICLES

Regulation of production and secretion of sex hormone-binding globulin in HepG2 cell cultures by hormones and growth factors

M Loukovaara, M Carson and H Adlercreutz
Department of Clinical Chemistry, University of Helsinki, Meilahti Hospital, Finland.

Regulation of the production and secretion of sex hormone-binding globulin (SHBG) was investigated in HepG2 cell cultures by measuring SHBG protein concentrations intra- and extracellularly and studying changes in SHBG messenger ribonucleic acid levels. Insulin (10 nmol/L), insulin-like growth factor-I (15 nmol/L), and epidermal growth factor (20 nmol/L) decreased SHBG levels in parallel both intra- and extracellularly. Ten nmol/L 17 beta-estradiol, 10 nmol/L testosterone, and 100 nmol/L to 1 mumol/L cortisol increased SHBG levels inside the cells, but did not increase its release into the culture medium. Two hundred and fifty to 500 nmol/L 17 beta-estradiol and 500 nmol/L to 1 mumol/L testosterone increased SHBG levels intra- and extracelularly, but relative to control values, the increase was considerably greater inside the cells. T3 (10 nmol/L) increased SHBG levels, but unlike the effect seen with steroids, the increase was equally evident within the cells and the medium. Northern hybridization showed that insulin decreased and 17 beta-estradiol and T3 increased SHBG messenger ribonucleic acid levels marginally. The variable secretion of SHBG is hypothesized to be due to the different effects of hormones and growth factors on either the glycan moiety of SHBG or the expression of the alternatively spliced transcripts of the SHBG gene.

This article has been cited by other articles:

				A.-M. Andersson, T. K. Jensen, A. Juul, J. H. Petersen, T. Jorgensen, and N. E. Skakkebaek Secular Decline in Male Testosterone and Sex Hormone Binding Globulin Serum Levels in Danish Population Surveys J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4696 - 4705. [Abstract] [Full Text] [PDF]

				C. Sweeney, G. Liu, C. Yiannoutsos, J. Kolesar, D. Horvath, M. J. Staab, K. Fife, V. Armstrong, A. Treston, C. Sidor, et al. A Phase II Multicenter, Randomized, Double-Blind, Safety Trial Assessing the Pharmacokinetics, Pharmacodynamics, and Efficacy of Oral 2-Methoxyestradiol Capsules in Hormone-Refractory Prostate Cancer Clin. Cancer Res., September 15, 2005; 11(18): 6625 - 6633. [Abstract] [Full Text] [PDF]

				A. Karagiannis and F. Harsoulis Gonadal dysfunction in systemic diseases Eur. J. Endocrinol., April 1, 2005; 152(4): 501 - 513. [Abstract] [Full Text] [PDF]

				K. Sutton-Tyrrell, R. P. Wildman, K. A. Matthews, C. Chae, B. L. Lasley, S. Brockwell, R. C. Pasternak, D. Lloyd-Jones, M. F. Sowers, J. I. Torrens, et al. Sex Hormone-Binding Globulin and the Free Androgen Index Are Related to Cardiovascular Risk Factors in Multiethnic Premenopausal and Perimenopausal Women Enrolled in the Study of Women Across the Nation (SWAN) Circulation, March 15, 2005; 111(10): 1242 - 1249. [Abstract] [Full Text] [PDF]

				M. Sowers, C. Derby, M. L. Jannausch, J. I. Torrens, and R. Pasternak Insulin Resistance, Hemostatic Factors, and Hormone Interactions in Pre- and Perimenopausal Women: SWAN J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4904 - 4910. [Abstract] [Full Text] [PDF]

				J. Cornish, K. E. Callon, K. G. Mountjoy, U. Bava, J.-M. Lin, D. E. Myers, D. Naot, and I. R. Reid alpha -Melanocyte-stimulating hormone is a novel regulator of bone Am J Physiol Endocrinol Metab, June 1, 2003; 284(6): E1181 - E1190. [Abstract] [Full Text] [PDF]

				G. M. Kalish, E. Barrett-Connor, G. A. Laughlin, and B. I. Gulanski Association of Endogenous Sex Hormones and Insulin Resistance among Postmenopausal Women: Results from the Postmenopausal Estrogen/Progestin Intervention Trial J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1646 - 1652. [Abstract] [Full Text] [PDF]

				M. Wolf, L. Sandler, K. Munoz, K. Hsu, J. L. Ecker, and R. Thadhani First Trimester Insulin Resistance and Subsequent Preeclampsia: A Prospective Study J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1563 - 1568. [Abstract] [Full Text] [PDF]

				D. M. Berman, L. M. Rodrigues, B. J. Nicklas, A. S. Ryan, K. E. Dennis, and A. P. Goldberg Racial Disparities in Metabolism, Central Obesity, and Sex Hormone-Binding Globulin in Postmenopausal Women J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 97 - 103. [Abstract] [Full Text]

				A. M. Pino, L. E. Valladares, M. A. Palma, A. M. Mancilla, M. Yáñez, and C. Albala Dietary Isoflavones Affect Sex Hormone-Binding Globulin Levels in Postmenopausal Women J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2797 - 2800. [Abstract] [Full Text]

				M. Janne and G. L. Hammond Hepatocyte Nuclear Factor-4 Controls Transcription from a TATA-less Human Sex Hormone-binding Globulin Gene Promoter J. Biol. Chem., December 18, 1998; 273(51): 34105 - 34114. [Abstract] [Full Text] [PDF]

				D. Simon, M.-A. Charles, K. Nahoul, G. Orssaud, J. Kremski, V. Hully, E. Joubert, L. Papoz, and E. Eschwege Association between Plasma Total Testosterone and Cardiovascular Risk Factors in Healthy Adult Men: The Telecom Study J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 682 - 685. [Abstract] [Full Text] [PDF]